Dalbavancin Use in Vulnerable Patients Receiving Outpatient Parenteral Antibiotic Therapy for Invasive Gram-Positive Infections

Dalbavancin Use in Vulnerable Patients Receiving Outpatient Parenteral Antibiotic Therapy for Invasive Gram-Positive Infections

Abstract Introduction Dalbavancin is approved for acute bacterial skin and skin structure infections (ABSSSIs) but offers a potential treatment option for complicated invasive gram-positive infections. Importantly, dalbavancin’s real benefits may be in treating complicated infections in vulnerable p...

Full description

Bibliographic Details
Main Authors: Jacqueline T. Bork, Emily L. Heil, Shanna Berry, Eurides Lopes, Rohini Davé, Bruce L. Gilliam, Anthony Amoroso
Format: Article
Language:English
Published: Adis, Springer Healthcare 2019-05-01
Series:Infectious Diseases and Therapy
Subjects:
Dalbavancin
Outpatient parenteral antibiotic therapy
Substance use disorder
Online Access:http://link.springer.com/article/10.1007/s40121-019-0247-0

Internet

http://link.springer.com/article/10.1007/s40121-019-0247-0

Similar Items